Overview

A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

Status:
Completed
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
The primary purpose for this study is to assess recurrence of Actinic Keratosis in participants achieving complete response treated in earlier study.
Phase:
Phase 3
Details
Lead Sponsor:
Galderma R&D
Treatments:
Aminolevulinic Acid
Methyl 5-aminolevulinate